Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 28, 2025 08:00 ET | Source: Tidewave Biotech Inc

Tidewave Bio Completes FDA INTERACT Meeting for TBC-1, a Universal Cell Therapy Platform in Solid Tumors

Tidewave Bio completes FDA INTERACT meeting for TBC-1, advancing its universal cell therapy toward pre-IND and IND/CTA to address solid tumors.
August 07, 2025 08:00 ET | Source: Tidewave Biotech Inc

Tidewave Bio Reaches Key Regulatory Milestone with FDA INTERACT Meeting Scheduled for August 2025

LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Tidewave Bio, a biotechnology company developing a novel immune activation platform for solid tumors, today announced that the U.S. Food and Drug...